The government of Finland is stepping up action to prevent counterfeit medicines from entering the country’s drug supply chain. When importing into Finland from outside the European Economic Area (EEA), the amended Finnish Medicines Act requires ingredients intended to be used in medicines to hold a written authority statement stipulating the good manufacturing practice (GMP) of the country of export. Medicine suppliers are to register with the Finnish Medicines Agency (FIMEA) and people working in the pharmaceutical sector are obligated to report products suspected to be fake to the authorities. The act comes into effect January 1, 2014.
To read more about the Finnish Medicines Act click here.
To read FIMEA page on counterfeit medicines click here.
